• Balsalazide Disodium: Novel 5-ASA Prodrug for Ulcerative Col

  2026-05-31

  The reference study by Wiggins & Rajapakse synthesizes clinical evidence on balsalazide disodium, a 5-aminosalicylate prodrug formulated for targeted colonic release in ulcerative colitis. Their systematic review highlights the drug's rapid induction of remission, favorable safety, and mechanistic differentiation, providing a foundation for translational inflammation research.

• KPT-330 (Selinexor): Applied Workflows in Cancer Research

  2026-05-30

  KPT-330 (Selinexor) empowers precise dissection of CRM1-mediated nuclear export in cancer models, offering robust apoptosis induction and tumor growth inhibition with quantifiable, reproducible endpoints. This article details advanced workflow integration, troubleshooting, and data-driven insights for translational oncology researchers leveraging APExBIO’s benchmark CRM1 inhibitor.

• Sulfaphenazole Restores Perfusion and Reduces Pressure Injur

  2026-05-29

  Turner et al. reveal that sulfaphenazole, a CYP 2C6/2C9 inhibitor, rapidly restores tissue perfusion and attenuates the severity of thermal and pressure injuries in an aging mouse model. The work highlights the therapeutic potential of vascular protection strategies for ischemic skin injuries and offers a framework to guide translational research targeting reperfusion pathology.

• HyperScript First-Strand cDNA Synthesis Kit: Precision for L

  2026-05-29

  Explore how the HyperScript First-Strand cDNA Synthesis Kit enables sensitive, high-fidelity reverse transcription of low-abundance and structurally complex RNA, with unique insights for translational and clinical research. This article provides a practical, evidence-based guide for advanced assay design.

• Astrocyte Heterogeneity Mapped Across Mouse and Marmoset Bra

  2026-05-28

  Schroeder et al. present a comprehensive transcriptomic atlas that maps the molecular and morphological heterogeneity of astrocytes across brain regions and developmental stages in mouse and marmoset. The study reveals regionally specialized and evolutionarily conserved astrocyte populations, providing foundational insight for neuroscience research.

• Everolimus (RAD001): Decoding mTOR Inhibition in Cancer Rese

  2026-05-28

  Explore the multifaceted role of Everolimus (RAD001) as an mTOR pathway inhibitor in cancer research. This article uniquely dissects assay interpretation, mechanistic intricacies, and practical workflow implications, setting it apart from standard protocol guides.

• EZ Cap EGFP mRNA 5-moUTP: Advancing Robust Gene Expression A

  2026-05-27

  EZ Cap™ EGFP mRNA (5-moUTP) delivers high-fidelity, immune-evasive enhanced green fluorescent protein expression for demanding gene regulation, imaging, and translation efficiency studies. Its advanced modifications set a new standard for reproducibility and translational performance in both in vitro and in vivo workflows.

• Recent Synthetic Advances in Ibuprofen: Impacts on NSAID Res

  2026-05-27

  This review discusses newly developed synthetic strategies for ibuprofen and naproxen, focusing on improved efficiency, selectivity, and practical applicability. The innovations highlighted in the referenced study streamline nonsteroidal anti-inflammatory drug (NSAID) production and have downstream implications for inflammation pathway research and COX inhibitor development.

• Tacalcitol Enhances 5-FU Sensitivity in Colorectal Cancer Ce

  2026-05-26

  This article reviews a reference study demonstrating that tacalcitol, a synthetic analog of vitamin D3, increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating thymidylate synthase through vitamin D receptor signaling. These findings highlight a mechanistically distinct approach for improving chemotherapeutic efficacy while minimizing calcemic toxicity.

• Tetracycline in Research: Advanced Workflows and Optimizatio

  2026-05-26

  Tetracycline’s broad-spectrum action and ribosomal specificity empower microbiological research and complex translational models. This article distills cutting-edge experimental protocols, troubleshooting strategies, and marquee findings that leverage APExBIO’s Tetracycline for breakthrough results in selection, ER stress, and hepatic fibrosis studies.

• Cisplatin Mechanisms & Strategy: Next-Gen Translational Insi

  2026-05-25

  This article delivers an integrative thought-leadership perspective on cisplatin (CDDP), illuminating mechanistic underpinnings, experimental best practices, and translational strategies for overcoming chemotherapy resistance. Drawing on recent evidence—including gefitinib combination approaches in NSCLC—and leveraging APExBIO’s high-quality cisplatin (SKU: A8321), we offer actionable guidance for translational researchers seeking to advance the field beyond conventional protocols.

• Astrocytic GAT-3 Modulates Synaptic Transmission in Dentate

  2026-05-25

  This study reveals that astrocytic GAT-3 critically regulates synaptic transmission and memory formation in the dentate gyrus by modulating astrocytic calcium signaling and neurotransmitter release. The findings advance our molecular understanding of hippocampal cognitive mechanisms and suggest new directions for targeting astrocyte-mediated processes in cognitive disorders.

• Bone Transport Accelerates Diabetic Foot Ulcer Healing via T

  2026-05-24

  This study demonstrates that bone transport surgery promotes diabetic foot ulcer healing by activating TGF-β1-mediated angiogenic and immune pathways. The findings define a mechanistic link between osteogenesis, angiogenesis, and immunomodulation, highlighting the TGF-β1/TGFBR1 axis as a promising target for chronic wound therapy.

• LY2109761: Advancing TGF-β Pathway Modulation in Translation

  2026-05-23

  This thought-leadership article unveils the strategic potential of LY2109761, a potent TGF-β receptor type I and II dual inhibitor, for translational oncology and fibrotic disease research. Integrating mechanistic insights, recent evidence, and practical guidance, it equips researchers to exploit Smad2/3 signaling blockade for breakthroughs in tumor biology, radiosensitization, and fibrosis, while contextualizing LY2109761 amid the evolving competitive landscape.

• SIRT1-Regulated Ran Lactylation Drives Astrocyte Polarizatio

  2026-05-22

  This study uncovers a novel mechanism linking lactate metabolism to astrocyte polarization following spinal cord injury. By demonstrating that SIRT1-regulated lactylation of Ran at lysine 123 is essential for STAT3-driven astrocyte responses, the findings offer new molecular targets for modulating CNS repair.

14728 records 1/982 page Next 12345 下5页 Last page